Topic: Simponi

UPDATE 1-Merck sees fast ruling in J&J Remicade arbitration

Reuters - 2 days ago
Expects proceeding to begin in late September . . * Sees it lasting no more than 12 business days. . * Expects decision within 20 days after...

Arthritis drugs raise cancer risk in kids: FDA

Reuters US Online Report Health News - 400 days ago
WASHINGTON (Reuters) - Blockbuster prescription drugs used to treat rheumatoid arthritis and other conditions can increase the risk of potentially deadly cancer in children and teenagers, U.S. health regulators said on Tuesday in ordering stronger warning

FDA clears potential blockbuster arthritis drug

AP News - 501 days ago
FDA clears Johnson & Johnson's successor to the blockbuster arthritis drug RemicadeThe Food and Drug Administration on Friday approved a potential blockbuster drug from Johnson & Johnson that fights three forms of arthritis caused by i